Use of encapsulated stem cells to overcome the bottleneck of cell availability for cell therapy approaches

Transfusion Medicine and Hemotherapy

Volumn 37, Issue 2, 2010, Pages 66-73

  Freimark, D ^a   Pino Grace, P P ^a   Pohl, S ^a   Weber, C ^a   Wallrapp, C ^b   Geigle, P ^b   Portner R ^c   Czermak, P ^a,d  

^a UNIVERSITY OF APPLIED SCIENCES   (Germany)

^b CellMed AG   (Germany)

^c HAMBURG UNIVERSITY OF TECHNOLOGY   (Germany)

^d Sunflower Networking Group   (United States)

Author keywords

Cell therapy; Encapsulation; Stem cells

Indexed keywords

GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR;

BIOREACTOR; CELL CULTURE; CELL DIFFERENTIATION; CELL ENCAPSULATION; CELL EXPANSION; CELL MATURATION; CELL PROTECTION; CELL SURVIVAL; CELL THERAPY; FIBROBLAST; GENETIC ENGINEERING; HUMAN; IMMUNE RESPONSE; MESENCHYMAL STEM CELL; MULTIPOTENT STEM CELL; NONHUMAN; REGENERATIVE MEDICINE; REVIEW; STEM CELL; STEM CELL TRANSPLANTATION;

EID: 77951112533     PISSN: 16603796     EISSN: None     Source Type: Journal    
DOI: 10.1159/000285777     Document Type: Review

References (63)

1. Gage FH: Cell therapy. Nature 1998;392(6679 suppl):18-24.
2. Morris PJ: Immunoprotection of therapeutic cell transplants by encapsulation. Trends Biotechnol 1996;14(5):163-167.
3. Rihova B: Immunocompatibility and biocompatibility of cell delivery systems. Adv Drug Deliv Rev 2000;42(1-2):65-80.
4. Li RH: Materials for immunoisolated cell transplantation. Adv Drug Deliv Rev 1998;33(1-2): 87-109.
5. Uludag H, De Vos P, Tresco PA: Technology of mammalian cell encapsulation. Advanced Drug Delivery Rev 2000;42(1-2):29-64.
6. Shoichet MS, Li RH, White ML, Winn SR: Stability of hydrogels used in cell encapsulation: An in vitro comparison of alginate and agarose. Biotechnol Bioeng 1996;50(4):374-381.
7. Zimmermann H, Shirley SG, Zimmermann U: Alginate- based encapsulation of cells: past, present, and future. Curr Diab Rep 2007;7(4):314-320.
8. Rabanel JM, Banquy X, Zouaoui H, Mokhtar M, Hildgen P: Progress technology in microencapsulation methods for cell therapy. Biotechnol Prog 2009;25(4):946-963.
9. Gianello P, Dufrane D: Correction of a diabetes mellitus type 1 on primate with encapsulated islet of pig pancreatic transplant (in French). Bull Mem Acad R Med Belg 2007;162(10-12):439-449; discussion 449-450.
10. Thanos CG, Elliott RB: Encapsulated porcine islet transplantation: an evolving therapy for the treatment of type I diabetes. Expert Opin Biol Ther 2009;9(1):29-44.
11. Black SP, Constantinidis I, Cui H, Tucker-Burden C, Weber CJ, Safley SA: Immune responses to an encapsulated allogeneic islet beta-cell line in diabetic NOD mice. Biochem Biophys Res Commun 2006;340(1):236-243.
12. Altman JJ, Houlbert D, Chollier A, Leduc A, Mc-Millan P, Galletti PM: Encapsulated human islet transplants in diabetic rats. Trans Am Soc Artif Intern Organs 1984;30:382-386.
13. Elliott RB, Escobar L, Tan PL, Muzina M, Zwain S, Buchanan C: Live encapsulated porcine islets from a type 1 diabetic patient 9.5 yr after xenotransplantation. Xenotransplantation 2007;14(2):157-161.
14. Scheen AJ: Clinical study of the month. Prolonged insulin independence after transplantation of islets of Langerhans in a patient with type 1 diabetes: achievement of a dream? (in French). Rev Med Liege 2000;55(8):803-805.
15. Calafiore R, Basta G, Luca G, Lemmi A, Montanucci MP, Calabrese G, Racanicchi L, Mancuso F, Brunetti P: Microencapsulated pancreatic islet allografts into nonimmunosuppressed patients with type 1 diabetes: first two cases. Diabetes Care 2006; 29(1):137-138.
16. Emerich DF, Vasconcellos AV, Elliott RB, Skinner SJ, Borlongan CV: The choroid plexus: function, pathology and therapeutic potential of its transplantation. Expert Opin Biol Ther 2004; 4(8):1191-1201.
17. Borlongan CV, Thanos CG, Skinner SJ, Geaney M, Emerich DF: Transplants of encapsulated rat choroid plexus cells exert neuroprotection in a rodent model of Huntington's disease. Cell Transplant 2008;16(10):987-992.
18. Emerich DF, Thanos CG, Goddard M, Skinner SJ, Geany MS, Bell WJ, Bintz B, Schneider P, Chu Y, Babu RS, Borlongan CV, Boekelheide K, Hall S, Bryant B, Kordower JH: Extensive neuroprotection by choroid plexus transplants in excitotoxin lesioned monkeys. Neurobiol Dis 2006;23(2): 471-480.
19. Jeon Y, Kwak K, Kim S, Kim Y, Lim J, Baek W: Intrathecal implants of microencapsulated xenogenic chromaffin cells provide a long-term source of analgesic substances. Transplant Proc 2006; 38(9):3061-3065.
20. Yasuhara T, Date I: Intracerebral transplantation of genetically engineered cells for Parkinson's disease: toward clinical application. Cell Transplant 2007;16(2):125-132.
21. Sajadi A, Bensadoun JC, Schneider BL, Lo Bianco C, Aebischer P: Transient striatal delivery of GDNF via encapsulated cells leads to sustained behavioral improvement in a bilateral model of Parkinson disease. Neurobiol Dis 2006;22(1):119-129.
22. Consiglio A, Martino S, Dolcetta D, Cusella G, Conese M, Marchesini S, Benaglia G, Wrabetz L, Orlacchio A, Deglon N, Aebischer P, Severini GM, Bordignon C: Metabolic correction in oligodendrocytes derived from metachromatic leukodystrophy mouse model by using encapsulated recombinant myoblasts. J Neurol Sci 2007;255(1-2):7-16.
23. Zhang H, Zhu SJ, Wang W, Wei YJ, Hu SS: Transplantation of microencapsulated genetically modified xenogeneic cells augments angiogenesis and improves heart function. Gene Ther 2008;15(1):40-48.
24. Nakama H, Ohsugi K, Otsuki T, Date I, Kosuga M, Okuyama T, Sakuragawa N: Encapsulation cell therapy for mucopolysaccharidosis type VII using genetically engineered immortalized human amniotic epithelial cells. Tohoku J Exp Med 2006; 209(1):23-32
25. Murua A, de Castro M, Orive G, Hernandez RM, Pedraz JL: In vitro characterization and in vivo functionality of erythropoietin-secreting cells immobilized in alginate-poly-L-lysine-alginate microcapsules. Biomacromolecules 2007;8(11):3302-3307.
26. Murua A, Orive G, Hernandez RM, Pedraz JL: Xenogeneic transplantation of erythropoietin-secreting cells immobilized in microcapsules using transient immunosuppression. J Control Release 2009; 137(3):174-178.
27. Moran DM, Koniaris LG, Jablonski EM, Cahill PA, Halberstadt CR, McKillop IH: Microencapsulation of engineered cells to deliver sustained high circulating levels of interleukin-6 to study hepatocellular carcinoma progression. Cell Transplant 2006;15(8-9):785-798.
28. Sieving PA, Caruso RC, Tao W, Coleman HR, Thompson DJ, Fullmer KR, Bush RA: Ciliary neurotrophic factor (CNTF) for human retinal degeneration: phase I trial of CNTF delivered by encapsulated cell intraocular implants. Proc Natl Acad Sci U S A 2006;103(10):3896-3901.
29. Puymirat E, Geha R, Tomescot A, Bellamy V, Larghero J, Trinquart L, Bruneval P, Desnos M, Hagege A, Puceat M, Menasche P: Can mesenchymal stem cells induce tolerance to cotransplanted human embryonic stem cells? Mol Ther 2008;17(1):176-182.
30. Niemeyer P, Seckinger A, Simank HG, Kasten P, Sudkamp N,Krause U: Allogenic transplantation of human mesenchymal stem cells for tissue engineering purposes: an in vitro study (in German). Orthopäde 2004;33(12):1346-1353.
31. Biehl JK, Russell B: Introduction to stem cell therapy. J Cardiovasc Nurs 2009;24(2):98-103.
32. Bajada S, Mazakova I, Richardson JB, Ashammakhi N: Updates on stem cells and their applications in regenerative medicine. J Tissue Eng Regen Med 2008;2(4):169-183.
33. Feng B, Ng JH, Heng JC, Ng HH: Molecules that promote or enhance reprogramming of somatic cells to induced pluripotent stem cells. Cell Stem Cell 2009;4(4):301-312.
34. Blum B, Benvenisty N: The tumorigenicity of human embryonic stem cells. Adv Cancer Res 2008; 100:133-158.
35. Evans-Molina C, Vestermark GL, Mirmira RG: Development of insulin-producing cells from primitive biologic precursors. Curr Opin Organ Transplant 2009;14(1):56-63.
36. McDonald JW, Becker D, Holekamp TF, Howard M, Liu S, Lu A, Lu J, Platik MM, Qu Y, Stewart T, Vadivelu S: Repair of the injured spinal cord and the potential of embryonic stem cell transplantation. J Neurotrauma 2004;21(4):383-393.
37. Haruta M: Embryonic stem cells: potential source for ocular repair. Semin Ophthalmol 2005; 20(1):17-23.
38. Taylor H, Minger SL: Regenerative medicine in Parkinson's disease: generation of mesencephalic dopaminergic cells from embryonic stem cells. Curr Opin Biotechnol 2005;16(5):487-492.
39. Price FD, Kuroda K, Rudnicki MA: Stem cell based therapies to treat muscular dystrophy. Biochim Biophys Acta 2007;1772(2):272-283.
40. Pillekamp F, Khalil M, Emmel M, Brockmeier K, Hescheler J: Stem cells in pediatric heart failure. Minerva Cardioangiol 2008;56(3):335-348.
41. Thomas ED: Bone marrow transplantation: prospects for leukemia and other conditions. Proc Inst Med Chic 1975;30(8):256-258.
42. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR: Multilineage potential of adult human mesenchymal stem cells. Science 1999;284(5411):143-147.
43. Tuli R, Seghatoleslami MR, Tuli S, Wang ML, Hozack WJ, Manner PA, Danielson KG, Tuan RS: A simple, high-yield method for obtaining multipotential mesenchymal progenitor cells from trabecular bone. Mol Biotechnol 2003;23(1):37-49. (Pubitemid 36106222)
44. Fraser JK, Wulur I, Alfonso Z, Hedrick MH: Fat tissue: an underappreciated source of stem cells for biotechnology. Trends Biotechnol 2006;24(4): 150-154.
45. Weber C, Gokorsch S, Czermak P: Expansion and chondrogenic differentiation of human mesenchymal stem cells. Int J Artif Organs 2007;30(7): 611-618.
46. Cai X, Lin Y, Ou G, Luo E, Man Y, Yuan Q, Gong P: Ectopic osteogenesis and chondrogenesis of bone marrow stromal stem cells in alginate system. Cell Biol Int 2007;31(8):776-783. (Pubitemid 46765134)
47. Freimark D, Czermak P: Cell-based regeneration of intervertebral disc defects: review and concepts. Int J Artif Organs 2009;32(4):197-203.
48. Ohnishi S, Nagaya N: Prepare cells to repair the heart: mesenchymal stem cells for the treatment of heart failure. Am J Nephrol 2007;27(3):301-307.
49. Mathur A, Martin JF: Stem cells and repair of the heart. Lancet 2004;364(9429):183-192.
50. Poulsom R, Alison MR, Cook T, Jeffery R, Ryan E, Forbes SJ, Hunt T, Wyles S, Wright NA: Bone marrow stem cells contribute to healing of the kidney. J Am Soc Nephrol 2003;14(suppl 1):S48-54.
51. Heile AM, Wallrapp C, Klinge PM, Samii A, Kassem M, Silverberg G, Brinker T: Cerebral transplantation of encapsulated mesenchymal stem cells improves cellular pathology after experimental traumatic brain injury. Neurosci Lett 2009; 463(3):176-181.
52. Ding HF, Liu R, Li BG, Lou JR, Dai KR, Tang TT: Biologic effect and immunoisolating behavior of BMP-2 gene-transfected bone marrow-derived mesenchymal stem cells in APA microcapsules. Biochem Biophys Res Commun 2007;362(4):923-927.
53. Babister JC, Tare RS, Green DW, Inglis S, Mann S, Oreffo RO: Genetic manipulation of human mesenchymal progenitors to promote chondrogenesis using 'bead-in-bead' polysaccharide capsules. Biomaterials 2008;29(1):58-65.
54. Braccini A, Wendt D, Jaquiery C, Jakob M, Heberer M, Kenins L, Wodnar-Filipowicz A, Quarto R, Martin I: Three-dimensional perfusion culture of human bone marrow cells and generation of osteoinductive grafts. Stem Cells 2005;23(8):1066-1072.
55. Catapano G, Czermak P, Eibl R, Eibl D, Pörtner R: Bioreactor design and scale-up; in Eibl R, et al (eds): Cell and Tissue Reaction Engineering. Berlin, Springer 2008, pp 363.
56. Zhao F, Ma T: Perfusion bioreactor system for human mesenchymal stem cell tissue engineering: dynamic cell seeding and construct development. Biotechnol Bioeng 2005;91(4):482-493
57. Chen X, Xu H, Wan C, McCaigue M, Li G: Bioreactor expansion of human adult bone marrowderived mesenchymal stem cells. Stem Cells 2006; 24(9):2052-2059.
58. Weber C, Pohl S, Portner R, Wallrapp C, Kassem M, Geigle P, Czermak P: Expansion and harvesting of hMSC-TERT. Open Biomed Eng J 2007;1:38-46.
59. Weber C, Pohl S, Poertner R, Pino-Grace P, Wallrapp C, Geigle P, Czermak P: Bioreactor system for expansion and differentiation of human mesenchymal stem cells: design and scale-up strategy. GIT Bioprocessing 2009;1:9-13.
60. Weber C, Pohl S, Poertner R, Pino-Grace P, Wallrapp C, Geigle P, Czermak P: Production process for stem cell based therapeutic implants: expansion of the production cell line and cultivation of encapsulated cells. Adv Biochem Eng Biotechnol 2010; DOI: 10.1007/10-2009-25.
61. Weber C, Pohl S, Portner R, Wallrapp C, Kassem M, Geigle P, Czermak P: Cultivation and differentiation of encapsulated hMSC-TERT in a disposable small-scale syringe-like fixed bed reactor. Open Biomed Eng J 2007;1:64-70.
62. Hinz DC: Process analytical technologies in the pharmaceutical industry: the FDA's PAT initiative. Anal Bioanal Chem 2006;384(5):1036-1042.
63. Simonsen JL, Rosada C, Serakinci N, Justesen J, Stenderup K, Rattan SIS, Jensen TG, Kassem M: Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells. Nat Biotech 2002;20(6):592-596.